SLC25A37 and hepatocellular carcinoma: Evidence from in vitro and in vivo studies has also suggested that the downregulation of mitoferrin-1 detected in hepatocellular carcinoma cells drives cell survival and tumor growth by minimizing mitochondrial iron-induced ferroptosis [32].